Additionally, berberine has been shown to inhibit the phosphorylation of forkhead box O1 (FoxO1) and Akt in rats with bile duct ligation-induced liver fibrosis and in HSCs, further supporting its potential as a treatment for liver fibrosis [173]. Here, AKT1 is linked to Hepatic fibrosis.